ABSTRACT. Through oxygen free radical production, xanthine oxidase (XOD, E.C.1.2.3.2) has been implicated in the pathogenesis of postischemic and hyperoxic tissue injuries among newborn. We measured the activity and evaluated the kinetic characteristics of XOD in human fetal liver, intestine, brain, and myocardium. Both the fetal liver and intestine contain a high XOD activity through gestation. The activity increases in the liver and decreases in the intestine with advancing gestation. The apparent Km for hypoxanthine is 4.8-5.5 pM in the intestine throughout gestation and in the liver at term but higher than 30 pM in the liver during the first half of pregnancy. The activity is undetectable both in the fetal brain and myocardium throughout gestation. Thus, XOD activity is present at least in the liver and intestine to account for the oxidation of hypoxanthine and xanthine. However, direct evidence for adenine nucleotide catabolism, followed by oxidation of the accumulated hypoxanthine during tissue reoxygenation in the human liver or intestine is not available. (Pediatr Res 27: [286][287][288]1990) 
burst of superoxide radical and hydrogen peroxide production, and possibly tissue injury (2, 5, 11) . This mechanism has been strongly implicated in the pathogenesis of ischemia-reperfusion injury of the small intestine (1 [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] .
Tissue damage in the CNS, lungs, myocardium, liver, and intestine is common among extremely premature infants. A role for the hypoxanthine-XOD system in the pathogenesis of several prematurity-related problems, including bronchopulmonary dysplasia, necrotizing enterocolitis, and retinopathy of prematurity has been suggested (16, 17) . Yet, evidence for this hypothesis is mostly circumstantial, and essential data concerning the activity of XOD in fetal tissues as well as its kinetic characteristics during fetal development are lacking.
The aim of our study was to measure the activity and substrate affinity of XOD in the liver, brain, myocardium, and intestine during human fetal development.
MATERIALS AND METHODS [8-14C] hypoxanthine was obtained from Amersham International, Little Chalfont, UK; cellulose thin-layer plates from Eastman Kodak, Rochester, NY; NAD+ from Boehringer Mannheim, Mannheim, FRG; pyruvic acid and lactic dehydrogenase from Sigma Chemical, St. Louis, MO; and Aquasol from New England Nuclear, Boston, MA.
Fetal tissues were obtained from elective terminations, and neonatal tissues from necropsies. The fetal samples were taken within 2 h after termination, and the neonatal samples within 20 h after death. The material consisted of sam~les from 45 fetuses (10-20 gestational wk), nine preterm babies (25-28 wk), XOD (E.C. 1.2.1.37/1.2.3.2) catalyses the conversion of hy-and 15 term babies. The intestinal samples were taken from poxanthine to xanthine and on to uric acid. The enzyme exists proximal jejunum. None of the neonates had signs of necrotizing in viva predominantly as a NAD+-dependent deh~drogenase but enterocolitis or any other pathologic process of the intestine. All is converted to an ox~gen-de~endent oxidase reversibly by sulfiy-samples were quickly frozen and stored at -70°C. No decrease dry1 oxidation or irreversibly by proteolysis. The human enzyme in enzyme activity took place under these conditions. has an apparent Km of about 10-11 PM for h~~~x a n t h i n e in The tissue samples were homogenized with a Teflon pestle in the liver and jejunum, where the highest enzyme activity is found 5 ~0 1 of 100 mM T~~s -H c~, PH 8.0, containing 0.02% P-mercap-( 1-8).
toethanol, and sonicated for 15 s at 50 W three times on ice. The In the oxidation of hypoxanthine and xanthine, superoxide sonicates were then centrifuged at 10 000 x g for 20 min at radicals are generated. These, and secondary radicals ckrived +4"C, and the supernatants dialyzed against the homogenization from them, are capable of initiating chain-reactions resulting in buffer at +qc for 17 h. cell injury through lipid peroxidation, protein damage, etc. (9) .
The assay mixture contained 160 pM [8-'4C]hypoxanthine (sp XOD has been postulated to be the major source of superoxide act 50-60 mCi/mmol), 5 mM MgC12, 0.3 mM NAD+, 2 mM radicals during reoxygenation of postischemic tissues. During pyruvic acid, and 18 IU of lactic dehydrogenase (1 8), and 25 PL ischemia, hypoxanthine accumulates as a result of adenine nu-of sample in a total volume of 50 pL. The incubation was carried cleotide catabolism, and simultaneously xanthine dehydrogenase out at +37"C in air on an oscillating water bath, and terminated is converted into oxidase (10) . When oxygen is reintroduced to with 5 p~ of 4.2 N perchloric acid on ice. The mixture was the tissue during postischemic reperfusion, hypoxanthine is 0xi-subsequently neutralized with cold 4.42 N KOH, and centrifuged dized to xanthine and uric acid by the oxidase. The result is a at 800 x g for 10 rnin. A ~O -~L aliquot of the supernatant was ' Presented in part at the annual meeting of the European Society for Pediatric
The production xanthine and uric acid from (3, 19, 20) . Possible changes in the enzyme activity during the first 24 h after death were evaluated using samples of rabbit liver, and identical storage conditions. Blank values, obtained by adding perchloric acid and placing the tubes on ice before adding the isotope, were subtracted from the corresponding experimental values in all experiments.
All assays were performed in duplicate with three time points within the linear range of each assay. The Km and V, , , values were estimated from double-reciprocal plots. Protein was measured according to Peterson (2 1). In statistical analysis, Student's t test (two-sided) was used. Results are given as mean + SD.
RESULTS
The activity of XOD increased significantly in the fetal liver (Fig. 1A) but decreased in the intestine (Fig. 1B) toward term. The intestinal activity exceeded that in the liver 4-to 37-fold during the first two trimesters but settled at a similar level near term.
The hepatic enzyme had an apparent Km of more than 30 pM (V,,, 0.14 f 0.10 nmol/mg proteinlmin) for hypoxanthine during the first half of pregnancy but less than 6 pM (V,,, 1.6 5 0.3 nmol/mg proteinlmin) at term (Fig. 2) . The intestinal enzyme had a Km of 4.8 + 1.6 pM (V,,, 3.3 f 1.4 nmol/mg proteinlmin) for hypoxanthine throughout gestation.
In both the fetal brain and myocardium XOD activity was less than the limit of detection of the assay (0.02 nmol/mg protein/ min) throughout gestation. The enzyme activity did not change in samples of rabbit liver during storage at +4"C for up to 24 h after death.
DISCUSSION
Although the conversion of xanthine dehydrogenase to oxidase most likely was completed in our samples before assay, we decided to measure the combined activity, which does not seem to change during ischemia (10) .
Even though the activity of XOD in the fetal liver appears to increase with gestation, it remains roughly of the same magnitude as that reported in adult liver (4, 22) . The kinetic parameters of fetal hepatic XOD also appear to change. Its Km for hypoxanthine decreases as a function of gestational age, and at term is of the same magnitude as that in adult liver (3) .
In the human fetal intestine, the activity of XOD appears to decrease from a high level during early fetal life to adult levels (4) by term, and its Km for hypoxanthine is of the same magnitude as that in the adult intestine (3). Both the fetal hepatic and intestinal activities exceed that of the human trophoblast throughout gestation (1 9).
The kinetic characteristics of XOD, and the other major cytoplasmic hypoxanthine-metabolizing enzyme, HGPRT (E.C. 2.4.2.8), determine the fate of intracellular hypoxanthine. In adult human tissues, both HGPRT and XOD appear to have a Km of about 4-1 1 pM for hypoxanthine (3, 23) . The Km for hypoxanthine of hepatic HGPRT (about 59 pM) (Vettenranta K, Raivio KO, unpublished data) seems to be of the same magnitude as that of XOD during early fetal life but substantially higher near term. The hepatic activities of HGPRT (Vettenranta K, Raivio KO, unpublished data) and XOD seem to increase in varallel with advancing gestation. Thus, in the human fetal liver near term, the capacitf6 metabolize hypoxanthine appears high and its catabolism at low concentrations kinetically favored over reutilization.
The gestational change observed in the kinetic characteristics of hepatic XOD might well be explained by different isoforms of the enzyme. However, any data on dissimilar isoforms appearing in adult or fetal tissues have not been reported. In addition, even though the effect of several inhibitors on XOD activity has been demonstrated, their physiologic role as well as possible changes in that role with gestation also remain to be established (4) .
Conflicting data on the activity of XOD in the human adult brain have been reported (22, 25) . Our data appear to agree with those of Krenitsky and co-workers (25) in suggesting a low XOD activity in the human cerebrum.
Animal experiments have provided evidence suggesting a role for XOD in the pathogenesis of postischemic myocardial injury and dysfunction (26) (27) (28) . Differences in the myocardial activity of XOD between various mammalian species (29) have, however, prompted studies on its role in the pathogenesis of human myocardial injury. Our data on the human fetal heart are in agreement with those of the majority of previous investigators (30) (31) (32) (33) (34) , who could not find any or only trace amounts of XOD activity in adult human myocardium. Although Wajner and Harkness (22) recently reported high XOD activity in adult human heart, it thus appears more likely that XOD is not a significant source of oxygen free radicals in the human myocardium.
Although our data do not contradict the concept of XOD as a source of oxygen-free radicals in the neonatal postischemic liver (35) or intestine (12) by verifying the presence of XOD activity in these tissues throughout gestation, conclusions concerning in vivo mechanisms are difficult to draw from studies using disrupted cells. Consequently, the putative role of XOD in neonatal postischemic tissue injuries as well as the pathways of fetal hepatic and intestinal hypoxanthine catabolism, essentially remain to be further studied using, e.g. cultured cells and/or perfusion of the liver and intestine.
